Overview

Study of Lemborexant-Alcohol Interaction in Healthy Subjects

Status:
Completed
Trial end date:
2018-09-12
Target enrollment:
Participant gender:
Summary
This study will be conducted to evaluate the effects on cognitive performance (Power of Attention domain) and postural stability of lemborexant in combination with alcohol versus lemborexant alone and versus alcohol alone in healthy participants. This study will also assess the safety and tolerability of a single oral dose of lemborexant when administered alone or in combination with alcohol in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Eisai Inc.
Collaborator:
Purdue Pharma LP
Treatments:
Ethanol
Lemborexant